AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Mulsant, BH Pollock, BG Nebes, R Miller, MD Sweet, RA Stack, J Houck, PR Bensasi, S Mazumdar, S Reynolds, CF
Citation: Bh. Mulsant et al., A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients, AM J GER PS, 9(4), 2001, pp. 406-414

Authors: Sweet, RA Henteleff, RA Meinert, KA DeMichele, MAA Kirshner, MA Sorisio, DA Pollock, BG
Citation: Ra. Sweet et al., Antipsychotic radioreceptor assay: A modification identifying selective receptor effects, THER DRUG M, 23(4), 2001, pp. 421-426

Authors: Mulsant, BH Sweet, RA Rosen, J Pollock, BG Zubenko, GS Flynn, T Begley, AE Mazumdar, S Reynolds, CF
Citation: Bh. Mulsant et al., A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression inlate life, J CLIN PSY, 62(8), 2001, pp. 597-604

Authors: Sukonick, DL Pollock, BG Sweet, RA Mulsant, BH Rosen, J Klunk, WE Kastango, KB DeKosky, ST Ferrell, RE
Citation: Dl. Sukonick et al., The 5-HTTPRS/*L polymorphism and aggressive behavior in Alzheimer disease, ARCH NEUROL, 58(9), 2001, pp. 1425-1428

Authors: Sweet, RA Hamilton, RL Healy, MT Wisniewski, SR Henteleff, R Pollock, BG Lewis, DA DeKosky, ST
Citation: Ra. Sweet et al., Alterations of striatal dopamine receptor binding in Alzheimer disease areassociated with Lewy body pathology and antemortem psychosis, ARCH NEUROL, 58(3), 2001, pp. 466-472

Authors: Mamo, DC Sweet, RA Mulsant, BH Pollock, BG Miller, MD Stack, JA Begley, AE Reynolds, CF
Citation: Dc. Mamo et al., Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms - A prospective double-blind study in depressed elderly patients, AM J GER PS, 8(3), 2000, pp. 226-231

Authors: Sweet, RA Hamilton, RL Lopez, SL Klunk, WE Wisniewski, SR Kaufer, DI Healy, MT DeKosky, ST
Citation: Ra. Sweet et al., Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features, INT PSYCHOG, 12(4), 2000, pp. 547-558

Authors: Pollock, BG Ferrell, RE Mulsant, BH Mazumdar, S Miller, M Sweet, RA Davis, S Kirshner, MA Houck, PR Stack, JA Reynolds, CF Kupfer, DJ
Citation: Bg. Pollock et al., Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression, NEUROPSYCH, 23(5), 2000, pp. 587-590

Authors: Sweet, RA Pollock, BG Mulsant, BH Rosen, J Sorisio, D Kirshner, M Henteleff, R DeMichele, MAA
Citation: Ra. Sweet et al., Pharmacologic profile of perphenazine's metabolites, J CL PSYCH, 20(2), 2000, pp. 181-187

Authors: Lopez, OL Becker, JT Klunk, W Saxton, J Hamilton, RL Kaufer, DI Sweet, RA Meltzer, CC Wisniewski, S Kamboh, MI DeKosky, ST
Citation: Ol. Lopez et al., Research evaluation and diagnosis of probable Alzheimer's disease over thelast two decades: I, NEUROLOGY, 55(12), 2000, pp. 1854-1862

Authors: Lopez, OL Becker, JT Klunk, W Saxton, J Hamilton, RL Kaufer, DI Sweet, RA Meltzer, CC Wisniewski, S Kamboh, MI DeKosky, ST
Citation: Ol. Lopez et al., Research evaluation and diagnosis of possible Alzheimer's disease over thelast two decades: II, NEUROLOGY, 55(12), 2000, pp. 1863-1869

Authors: Wylie, ME Mulsant, BH Pollock, BG Sweet, RA Zubenko, GS Begley, AE Gregor, M Frank, E Reynolds, CF Kupfer, DJ
Citation: Me. Wylie et al., Age at onset in geriatric bipolar disorder - Effects on clinical presentation and treatment outcomes in an inpatient sample, AM J GER PS, 7(1), 1999, pp. 77-83

Authors: Mamo, DC Sweet, RA Keshavan, MS
Citation: Dc. Mamo et al., Managing antipsychotic-induced parkinsonism, DRUG SAFETY, 20(3), 1999, pp. 269-275
Risultati: 1-13 |